FDA changes review policy
Full Story
| Topics: FDA, medication, pharmaceutical
The New York Times reports an unannounced shift in FDA policy acknowledging that many drugs carry risks for psychiatric side effects. A questionnaire designed to measure suicidal thoughts, and developed by Columbia University's researcher Kelly L. Posner, led to the agency's reassessment.
